U.S. Markets closed

Array BioPharma Inc. (ARRY)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
11.60+0.08 (+0.69%)
At close: 4:00PM EDT

11.60 0.00 (0.00%)
After hours: 4:35PM EDT

People also watch
EXELCLDXARQLFOLDRIGL
  • S
    Sadie
    Sadie
    Ok folks, we are closing on breakout territory. We need to slice above 11.95. Above that there is only a single strength resistance at 13.25 before the 52 week high at 13.40 which is also single strength. Let's hope for a close above 11.95 by Thursday and confirmation the following day. If so we will be in breakout and momentum will be strong for continued upward movement.
  • D
    Doctor Jevago
    Doctor Jevago
    ARRY is opportunity of life time. Rare bird in the jungle of the market.
  • s
    sarath
    sarath
    If you have a Bloomberg, check it. You will see the Wells upgrade. Yes they really upgraded! It is not a rumor. I do not subscribe to rumors.
  • T
    Thanh
    Thanh
    It's pretty impressive how Array did the public offering with the stock going up from the offering price.
  • B
    Brendan Mc
    Brendan Mc
    $25 by December.
  • S
    S
    S
    Last reported short interest:
    8/31/2017 ... 23,808,509 .. built-in buyers..
  • A
    Alridge95
    Alridge95
    What is it with all the Nostradamus's here? Good news AH. Bad news AH. Will be quiet tomorrow. Going to the moon tomorrow.

    Give it up. None of us (me included) know a damn thing about whether there is good news after hours, pre-market, tomorrow, next week or next month. If it makes you feel better to make a prognostication then just keep saying the same thing every day, and one day you will likely be right. In the meantime, how about some real contributions here? What is the market for the combo, if approved? What does the European partner deal mean for Array's revenue prospects? What is the total financial position after the secondary? What is potential value of ARRY in a buyout and what is the potential upside from here? There are a million better things to post about than PPS projections over the next few hours. Seriously.
  • S
    S
    S
    IBB red - ARRY green - very bullish. Feels like it's ready to roll..
  • Y
    Yen Om
    Yen Om
    Sell now, get out before after hour bad news coming
  • T
    Todd
    Todd
    I have owned this stock for over 7 years, and have followed it diligently. This company is the real deal. I am not only glad for their success for personal monetary reasons, but also for the benefit this company and their research will bring to cancer patients. ARRY deserves the respect they are finally getting!!! These nice new price targets reflect the long overdue belief in this company and its pipeline.
  • B
    BRUNO
    BRUNO
    Psssst, ARRY was not in desperate need of cash by any means. Things are looking bright for the near future. CASH for......
    Spin Off of 797
    I believe ARRY knows Fast Track approval from FDA is coming.
    Cash ready to star new hires, a slew of job openings were posted on the ARRY website about 2 weeks (about 60-70) have since been removed, not sure why, maybe they don't want to jump the gun with the FDA.
    Manufacturing facilities ? ARRY was sitting on about $225million cash , secondary brought another $225 million and don't forget the milestone payments from Pierre Fabre
    Funds reaty to hir
  • Y
    Yen Om
    Yen Om
    How do I sell ARRY after hours, I want to put a stop loss sell in for $9.00 before it opens tomorrow - hearing this is pulling back hard, big options big shorts, spell big losses
  • B
    BRUNO
    BRUNO
    ARRY should play catch up to all the other oncology co's that have much less of a pipeline , than ARRY. Once they let this thing run well be in the upper teens or lower 20s
  • S
    S
    S
    Not much pre-market action, maybe things are going to calm down now.
  • A
    Atlantic
    Atlantic
    Yen Om or ying and yang?
    Bullish in the am? Now your a big bear
    You are a real POS
    Get lost
  • A
    Atlantic
    Atlantic
    To all the real longs here
    The idiot Yen Om is same short loser
    Sally, ellas, 0u812,
    I hope your boss knows you suck
    Only you would pump a BS hemp oil marijuana stock
    Lmfao
  • A
    Anonymous
    Anonymous
    An attempt to have more substantial discussions on this board:
    Remember when Novartis acquired the Oncology pipeline from GSK? They acquired dabrafenib and trametinib, directly competing with binimetinib and encorafenib that they had licensed from Array. Novartis decided to give the drugs back to Array because D+T were further in clinical development. Indeed for melanoma the combination D+T was granted in June of this year. Question is whether Array will be able to compete effectively with an entrenched market leader with significant marketing and sales power, once their own combination is approved in melanoma. I heard the arguments that there is less tox and may be a bit better efficacy, but beating an established market leader is always an uphill battle, certainly for a company that has to build op a marketing and sales organization. I am not sure that melanoma sales are going to impress, once approved.
    The story is different for colon cancer, very likely that they will be first to be approved there, but that is some 2 years away.
    How does the board view the melanoma opportunity.
    Disclosure: long, long, long
  • A
    Atlantic
    Atlantic
    Another BS prediction from yen om or dead money, predicted array down 2-3% everyday
    Said ah drop on bad news, only good news is he or she is hopefully getting fired from there minimum wage job pumping HOT AIR
  • B
    BRUNO
    BRUNO
    If the institutions own 103+% of the float, it doesn't leave much for the retail investor, I own 169k shares after the offering I moved all my assets into ARRY. I own more shares than Ron !!!!! maybe I can be the CEO and run the company, would you guy vote me in ?
  • r
    retiredceo2002
    retiredceo2002
    Offering closed at $10.75. Cohen bought all of it.

    Off to the races shortly.